Table 2.
CDOCKER energy | CDOCKER interaction energy | |||
---|---|---|---|---|
Wild type | C151W mutation | Wild type | C151W mutation | |
SFN | −20.7 ± 0.5c | −19.1 ± 1.0e,* | −19.1 ± 0.4bc | −17.8 ± 0.9a |
1 | −19.3 ± 0.7c | −22.5 ± 0.4g,** | −18.1 ± 0.6b | −21.1 ± 0.4b,## |
2 | −26.6 ± 0.2e | −21.4 ± 0.4fg,** | −28.9 ± 0.1de | −23.8 ± 0.4c,## |
3 | −23.8 ± 0.5d | −18.2 ± 0.7de,** | −29.2 ± 1.2de | −24.1 ± 0.8c,# |
4 | −24.7 ± 0.4de | −20.8 ± 0.1f,** | −30.8 ± 0.5e | −26.5 ± 0.3e,# |
5 | −16.2 ± 0.4b | −11.0 ± 1.1b,** | −30.1 ± 0.6de | −26.1 ± 1.1de,# |
6 | −15.3 ± 0.4ab | −9.3 ± 0.6a,*** | −29.4 ± 0.5de | −24.0 ± 1.0c,## |
7 | −14.0 ± 0.3a | −9.0 ± 0.2a,*** | −29.7 ± 0.9de | −24.5 ± 0.1cd,# |
8 | −19.9 ± 0.1c | −14.1 ± 0.2c,*** | −31.3 ± 0.4e | −25.0 ± 0.3cde,### |
9 | −14.8 ± 0.5ab | −9.8 ± 0.4ab,** | −27.7 ± 0.4d | −23.3 ± 1.0c,# |
10 | −13.6 ± 1.0a | −17.4 ± 0.2d,* | −14.7 ± 1.1a | −18.6 ± 0.1a,# |
11 | −21.0 ± 1.7c | −22.4 ± 0.4g | −21.4 ± 1.8c | −23.2 ± 0.2c |
Values with different letters are significantly different from each other (ANOVA followed by Tukey’s post hoc multiple range test, p < 0.05). The triple best fits were selected by CDOCER analysis using discovery studio 4.0. SFN, a representative antioxidant, and a C151 residue modifier, was used as a positive control. The significance was analyzed by the post hoc Turkey method (* p < 0.05, ** p < 0.01, *** p < 0.001 compared to the wild type of Keap1 in CDOCKER energy, # p < 0.05, ## p < 0.01, ### p < 0.001 compared to the wild type of Keap1 in CDOCKER interaction energy)